Efficacy and Safety of Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron for Glycemic Control Among Patients With Type 2 Diabetes: A Randomized Clinical Trial

Saxena, AR; Frias, JP; Brown, LS; Gorman, DN; Vasas, S; Tsamandouras, N; Birnbaum, MJ

Saxena, AR (通讯作者)，Pfizer Worldwide Res & Dev & Med, Internal Med Res Unit, One Portland St, Cambridge, MA 02139 USA.

JAMA NETWORK OPEN, 2023; 6 (5):

Abstract

IMPORTANCE Currently available glucagon-like peptide 1 receptor (GLP-1R) agonists for treating type 2 diabetes (T2D) are peptide agonists that require......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索